ArticleEuropean heart journal. Case reports2025
Intrapericardial localization of solitary fibrous tumour: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A solitary fibrous tumour (SFT) is a rare fibroblastic tumour, with primary cardiac SFT extremely rare. We report a rare case of a patient presenting with sudden dyspnoea who was diagnosed with a primary cardiac SFT. Case summary: A 56-year-old woman with a history of diabetes and active smoking presented with sudden dyspnoea. Computed tomography scan revealed a mass adjacent to the left ventricle. In addition to the large pericardial effusion, no signs of cardiac tamponade or valvulopathies were found on echocardiography. The patient underwent open-heart surgery and mass removal, finding a tumour located inside the pericardial sac and attached to the left ventricle's lateral wall; it did not invade other heart structures. Histological and immunohistochemical examination of the mass revealed SFT diagnosis. The patient was discharged from the hospital in full health, and follow-up examinations revealed no evidence of tumour recurrence. Discussion: Solitary fibrous tumour most commonly occurs in middle-aged patients and is not gender specific. Multimodal imaging is crucial for diagnosing and managing SFT. A definitive diagnosis must be based on both immunohistochemical and histopathological findings. STAT6 immunoexpression is the most reliable marker for histopathology diagnosis. Given the high SFT recurrence rate, follow-up is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.